Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review (Q35642930)

9 August 2017

1 reference

title

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review (English)

1 reference

9 August 2017

Steven Joffe

4

0 references

author name string

Jeffrey M Peppercorn

series ordinal

1

1 reference

9 August 2017

Jane C Weeks

series ordinal

2

1 reference

9 August 2017

E Francis Cook

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

363

1 reference

9 August 2017

issue

9405

1 reference

9 August 2017

page(s)

263-270

1 reference

Can a Clinical Trial be the Treatment of Choice for Patients With Cancer?1

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

The crisis in clinical cancer research. Third-party insurance and investigational therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Managed care and oncology: the quality debate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Access to quality cancer care: consensus statement. American Federation of Clinical Oncologic Societies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Leukemia in Rochester (NY). A 17-year experience with an analysis of the role of cooperative group (ECOG) participation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Results of a breast-cancer-surgery trial compared with observational data from routine practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Long-term survival in Hodgkin's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

The "inclusion benefit" in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Randomized and non-randomized patients in clinical trials: experiences with comprehensive cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Selection bias in clinical trials of anaplastic glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

The behavioral dynamics of clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Large-scale randomized evidence: large, simple trials and overviews of trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Socioeconomic status and cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Publication bias and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

Centralised treatment, entry to trials and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915383-4

7 January 2021

10.1016/S0140-6736(03)15383-4

Identifiers

DOI

1 reference

9 August 2017

1 reference